“We believe we can dramatically cut the time, cost and side effects involved in managing high blood pressure through the use of gene-specific treatment protocols,” says Fairview’s Dang Tran, MD, a principal investigator for the study.
All study participants will be asked to complete up to eight clinic visits over the course of 12 months, the cost of which would be covered by the study. Participants will only be responsible for the costs of prescribed medication and any lab tests that would normally be collected as a result of managing hypertension. Participants who attend all visits and complete all post-visit surveys will receive $100 in gift cards.
To be eligible, participants must be between the ages of 30 and 80, have a BMI between 19 and 50, and have a diagnosis of uncontrolled hypertension (high blood pressure) or be a newly diagnosed hypertensive patient. Participants do not need to be Fairview patients.
To enroll or learn more about the research study, please call 651-643-0295 or email email@example.com.